Loading news...
In the most recent trading session, Medpace (MEDP) closed at $582.48, indicating a -1.79% shift from the previous trading day.
Chicago Partners Investment Group LLC purchased a new stake in Medpace Holdings, Inc. (NASDAQ: MEDP) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,170 shares of the company's stock, valued at approximately $602,000. Other institutional investors and hedge
In the closing of the recent trading day, Medpace (MEDP) stood at $588.05, denoting a -3.01% move from the preceding trading day.
BloombergSen Inc. lifted its stake in Medpace Holdings, Inc. (NASDAQ: MEDP) by 48.8% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,756 shares of the company's stock after purchasing an additional 904 shares during the period. Medpace accounts
Harel Insurance Investments and Financial Services Ltd. reduced its holdings in Medpace Holdings, Inc. (NASDAQ: MEDP) by 31.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,510 shares of the company's stock after selling 5,232 shares during the quarter. Harel Insurance
Medpace (MEDP) closed at $616.45 in the latest trading session, marking a +1.32% move from the prior day.
Medical services stocks like MEDP, EHAB and PGNY benefit from tech-driven care models even as staffing gaps pressure margins.
Medpace (MEDP) closed the most recent trading day at $600.02, moving 2.13% from the previous trading session.
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2025 financial results after the market close on Monday, February 9, 2026. The Company will host a conference call the following morning, Tuesday, February 10, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is.
In the most recent trading session, Medpace (MEDP) closed at $561.65, indicating a -1.27% shift from the previous trading day.
Abacus FCF Advisors LLC lifted its holdings in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 23.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,663 shares of the company's stock after buying an additional 3,917 shares
Investors looking for stocks in the Medical Services sector might want to consider either BrightSpring Health Services, Inc. (BTSG) or Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Medpace (NASDAQ: MEDP - Get Free Report) and SBC Medical Group (NASDAQ: SBC - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation. Profitability This table compares Medpace and SBC Medical
In the latest trading session, Medpace (MEDP) closed at $568.36, marking a +1.45% move from the previous day.
Investors interested in stocks from the Medical Services sector have probably already heard of BrightSpring Health Services, Inc. (BTSG) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Fisher Asset Management LLC lessened its stake in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 29.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 125,347 shares of the company's stock after selling 53,245 shares during the quarter. Fisher Asset Management LLC
Stock News Prada acquires Versace: Prada Group (HKG:1913) completed a â¬1.25 billion deal to buy Versace from Capri Holdings (CPRI), bringing the brand under t
Medpace Holdings, Inc. (NASDAQ: MEDP - Get Free Report) CEO August Troendle sold 6,830 shares of Medpace stock in a transaction dated Thursday, November 20th. The stock was sold at an average price of $598.49, for a total value of $4,087,686.70. Following the completion of the sale, the chief executive officer directly owned 855,485 shares in
Clarkston Capital Partners LLC purchased a new stake in Medpace Holdings, Inc. (NASDAQ: MEDP) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 129,259 shares of the company's stock, valued at approximately $40,569,000. Clarkston Capital Partners LLC owned approximately 0.46% of Medpace
Coldstream Capital Management Inc. lowered its position in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 7.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,440 shares of the company's stock after selling 113 shares during the quarter. Coldstream